VistaGen Therapeutics, Inc.VTGNNASDAQ

Revenue (LTM)

$486000

-54.3% YoY

Net Income (LTM)

$-51M

-75.1% YoY

Free Cash Flow

$-42M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	1	1↑1.8%	-0↓120.5%	1↑568.7%	0↓54.3%
Gross Profit	1	1↑1.8%	-0↓120.5%	1↑568.7%	0↓54.3%
Operating Income	-18	-48↓166.4%	-59↓24.0%	-33↑44.3%	-56↓69.5%
Net Income	-18	-48↓166.3%	-59↓24.0%	-29↑50.4%	-51↓75.1%
EBITDA	-17	-47↓169.8%	-59↓24.8%	-32↑44.7%	-55↓70.5%
EPS Diluted	-14.74	-7.38↑49.9%	-8.51↓15.3%	-1.52↑82.1%	-1.67↓9.9%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	103	68↓33.9%	17↓75.6%	119↑616.2%	67↓43.7%
Total Current Assets	104	71↓31.8%	18↓75.3%	121↑589.3%	82↓32.0%
Total Assets	108	75↓31.1%	21↓71.7%	124↑486.3%	84↓31.8%
Total Current Liabilities	4	6↑37.6%	5↓20.7%	5↑12.0%	13↑146.2%
Total Liabilities	16	10↓39.1%	9↓9.3%	9↑4.0%	14↑48.9%
Total Equity	92	65↓29.6%	12↓81.3%	114↑846.1%	70↓38.4%
Total Debt	4	3↓18.3%	3↓10.8%	2↓21.8%	2↓28.8%
Net Debt	-99	-65↑34.5%	-14↑78.6%	-117↓740.4%	-66↑43.9%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	-12	-45↓274.8%	-50↓9.9%	-26↑48.1%	-42↓63.1%
Capital Expenditure	-0	-0↑27.2%	-0↓5.8%	-0↑71.2%	-0↓213.1%
Free Cash Flow	-12	-45↓268.1%	-50↓9.8%	-26↑48.2%	-42↓63.4%
Stock-Based Comp	2	3↑50.9%	3↓4.2%	2↓34.6%	4↑97.8%
Net Change in Cash	102	-35↓134.4%	-51↓47.2%	103↑299.1%	-52↓150.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance